Congratulating Zhejiang Haisheng Pharmaceutical Co., LTD
Release Date: 2023-11-16 Views: 672
Our client, Zhejiang Haisheng Pharmaceutical Co., LTD., successfully passed the 62nd Review Meeting of the Beijing Stock Exchange Listing Committee in 2023 on November 15, 2023!
In the sixth order in 2023, we will have another successful IPO customer。
- Previous: None
- Next post:He Wuxi Jinghai Amino Acid Co., Ltd. successfully met